Skip to main content

Table 4 Overall survival (in months) of EOPC and older PDAC cohorts

From: Demographic, clinical, and pathological features of early onset pancreatic cancer patients

 

Median survival (months)

 

EOPC (N = 35) (≤50 years)

PDAC (N = 334) (> 50 years)

p value

Entire cohorta

12 (5–18.9 95%CI)

9 (7.8–10.2 95%CI)

0.168

Stage I-II

25 (12.9–37 95%CI)

13(10.5–15.5 95%CI)

0.307

Stage III

11 (3.9–18.1 95%CI)

8 (6.5–9.4 95%CI)

0.172

Stage IV

6 (3.2–8.8 95%CI)

6 (4.8–7.2 95%CI)

0.213

  1. aData missing for three EOPC and nine PDAC patients
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us